New to Bioss? Enjoy 35% of your first order. Use code "FirstOrder35" - Offer valid for new U.S. Customers on direct orders only

CD160/By55 Polyclonal Antibody, Cy7 Conjugated

Applications

  • WB
  • FCM
  • IF(IHC-P)

Reactivity

  • Human
  • Rat

Predicted Reactivity

  • Mouse
  • Dog
Overview
Catalog # bs-2526R-Cy7
Product Name CD160/By55 Polyclonal Antibody, Cy7 Conjugated
Applications WB, FCM, IF(IHC-P)
Reactivity Human, Rat
Predicted Reactivity Mouse, Dog
Specifications
Conjugation Cy7
Host Rabbit
Source KLH conjugated synthetic peptide derived from human CD160
Immunogen Range 81-159/181
Clonality Polyclonal
Isotype IgG
Concentration 1ug/ul
Purification Purified by Protein A.
Storage Buffer Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Storage Condition Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Target
Gene ID 11126
Swiss Prot O95971
Subcellular location Cell membrane
Synonyms NK1; BY55; NK28; CD160 antigen; Natural killer cell receptor BY55; CD160
Background CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine rich, glycosylphosphatidylinositol anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule.
Application Dilution
WB 1:300-5000
FCM 1:20-100
IF(IHC-P) 1:50-200